Common Stock, Shares, Outstanding of Design Therapeutics, Inc. from 31 Dec 2020 to 31 Dec 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Design Therapeutics, Inc. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2020 to 31 Dec 2025.
  • Design Therapeutics, Inc. Common Stock, Shares, Outstanding for the quarter ending 31 Dec 2025 was 60,398,051, a 6.4% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

Design Therapeutics, Inc. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 60,398,051 +3,643,710 +6.4% 31 Dec 2025 10-K 09 Mar 2026 2025 FY
Q3 2025 56,963,757 +342,720 +0.6% 30 Sep 2025 10-Q 05 Nov 2025 2025 Q3
Q2 2025 56,948,126 +328,112 +0.58% 30 Jun 2025 10-Q 07 Aug 2025 2025 Q2
Q1 2025 56,768,678 +274,407 +0.49% 31 Mar 2025 10-Q 07 May 2025 2025 Q1
Q4 2024 56,754,341 +280,743 +0.5% 31 Dec 2024 10-K 09 Mar 2026 2025 FY
Q3 2024 56,621,037 +623,050 +1.1% 30 Sep 2024 10-Q 07 Nov 2024 2024 Q3
Q2 2024 56,620,014 +640,815 +1.1% 30 Jun 2024 10-Q 05 Aug 2024 2024 Q2
Q1 2024 56,494,271 +574,710 +1% 31 Mar 2024 10-Q 08 May 2024 2024 Q1
Q4 2023 56,473,598 +578,002 +1% 31 Dec 2023 10-K 10 Mar 2025 2024 FY
Q3 2023 55,997,987 +157,362 +0.28% 30 Sep 2023 10-Q 13 Nov 2023 2023 Q3
Q2 2023 55,979,199 +262,438 +0.47% 30 Jun 2023 10-Q 14 Aug 2023 2023 Q2
Q1 2023 55,919,561 +301,235 +0.54% 31 Mar 2023 10-Q 09 May 2023 2023 Q1
Q4 2022 55,895,596 +453,670 +0.82% 31 Dec 2022 10-K 19 Mar 2024 2023 FY
Q3 2022 55,840,625 +616,205 +1.1% 30 Sep 2022 10-Q 03 Nov 2022 2022 Q3
Q2 2022 55,716,761 +602,032 +1.1% 30 Jun 2022 10-Q 08 Aug 2022 2022 Q2
Q1 2022 55,618,326 +575,776 +1% 31 Mar 2022 10-Q 09 May 2022 2022 Q1
Q4 2021 55,441,926 +39,484,105 +247% 31 Dec 2021 10-K 14 Mar 2023 2022 FY
Q3 2021 55,224,420 30 Sep 2021 10-Q 09 Nov 2021 2021 Q3
Q2 2021 55,114,729 30 Jun 2021 10-Q 09 Aug 2021 2021 Q2
Q1 2021 55,042,550 31 Mar 2021 10-Q 10 May 2021 2021 Q1
Q4 2020 15,957,821 31 Dec 2020 10-K 10 Mar 2022 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.